根据中国商务部的声明，中国商务部长王文涛星期一在北京会见赛诺菲董事长弗雷德里克·乌代阿 (Frederic Oudea) 时说，“中国开放的大门只会越开越大，一视同仁支持企业开展科技创新、参与市场竞争，将为医药企业带来更多发展机遇。” ...

12月2日，跨国药企赛诺菲宣布，将投资约10亿欧元在北京亦庄设立全新生产制造基地，这将是赛诺菲在华第四个生产供应基地，创造了该企业在华最大单笔投资纪录，有望大幅提升胰岛素本地端到端生产制造能力，服务本土糖尿病患者的胰岛素用药需求。当天，赛诺菲与北京经 ...

据《新华社》报道，国务院副总理何立峰今日(3日)在人民大会堂会见会见法国药厂赛诺菲(Sanofi)董事会主席弗雷德里克-乌代阿一行。何立峰表示，内地正不断扩大高水平对外开放，持续打造市场化、法治化、国际化一流营商环境，欢迎包括赛诺菲集团在内的更多法国 ...

全球制药巨头、法国最大的医疗健康企业赛诺菲(Sanofi)与北京市经济和信息化局、北京经济技术开发区管委会昨日(2日)正式签署合作备忘录。

The French drugmaker said that the investment of about 1 billion euros will enhance the production and manufacturing of ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, which will ...

Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 ...

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in ...

Deutsche Bank lowered the firm’s price target on Sanofi (SNY) to EUR 85 from EUR 90 and keeps a Sell rating on the shares.Don't Miss our Black ...